Is a complete CSE/HEAL research report available?

No complete published report is available for cse/HEAL (CSE/HEAL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/HEAL (CSE/HEAL)

Canadian Securities Exchange: CSE/HEAL · CAD

CA$0.08

+0.00 (+7.1%)· Recorded snapshot

Market cap	4.7M
Revenue (ttm)	465.7K
Net income (ttm)	-1.7M
EPS (ttm)	-CA$0.04
Shares out	62.5M
Volume	6,000
Beta	-0.81

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 465.7K
Net income (ttm): -1.7M
EPS (ttm): -CA$0.04
Market cap: 4.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All CSE/HEAL indicators

Market & fundamental data

Available fields

168

Groups with data

Currency

CAD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 4.3M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA76134J2065
Last refreshed	2026-09-07
Market cap	CAD 4.7M
Price	CAD 0.08
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	cse/HEAL
Website	https://www.restartlife.co

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-36.5%
EV/Sales	9.18x
FCF yield	-20.92%
P/B ratio	3.54x
P/S ratio	10.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	41.36%
Gross Profit	CAD 192,636
Net Income	CAD -1.7M
Net Income Growth Years	0%
Pretax Margin	-367.41%
ROA	-100.4
Roa5y	-236.2
ROCE	-131.5
ROE	-246.7
ROIC	-126.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-28.67%
Cagr15y	-35.34%
Cagr1y	-6.25%
Cagr3y	-37%
Cagr5y	-39.82%
EPS Growth Years	0
Revenue Growth Qo Q	146.12x
Revenue Growth Years	0x
Revenue Growth5 Y	177.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.43
Assets	CAD 1.9M
Cash	CAD 762,363
Current Assets	CAD 1.1M
Current Liabilities	CAD 571,602
Debt	CAD 348,345
Debt Equity	CAD 0.26
Debt FCF	CAD -0.36
Equity	CAD 1.3M
Interest Coverage	-85.48
Liabilities	CAD 578,899
Long Term Assets	CAD 845,530
Long Term Liabilities	CAD 7,297
Net Cash	CAD 414,018
Net Cash By Market Cap	CAD 8.83
Net Cash Growth	57.79%
Net Debt Equity	CAD -0.31
Tangible Book Value	CAD 545,454
Tangible Book Value Per Share	CAD 0.01
WACC	0.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.85
Net Working Capital	CAD 65,200
Quick ratio	1.54
Working Capital	CAD 486,515
Working Capital Turnover	CAD 1.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-109.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-96.59%
1Y total return	-6.25%
200-day SMA	0.09
3Y total return	-75%
50-day SMA	0.09
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.11%
All Time High	1,228.8
All Time High Change	-99.99%
All Time High Date	2008-06-23
All Time Low	0.03
All Time Low Change	150%
All Time Low Date	2024-11-13
ATR	0.01
Beta	-0.81
Beta1y	-0.77
Beta2y	1.08
Ch YTD	-40
High	0.08
High52	0.14
High52 Date	2025-12-30
High52ch	-44.44%
Low	0.08
Low52	0.07
Low52 Date	2026-08-17
Low52ch	7.14%
Ma50ch	-16.01%
Price vs 200-day SMA	-20.38%
RSI	44.15
RSI Monthly	40.38
RSI Weekly	41.68
Sharpe ratio	1.2x
Sharpe Ratio3y	0.73x
Sharpe Ratio5y	0.67x
Sortino ratio	2.01
Sortino Ratio3y	1.28
Sortino Ratio5y	1.16
Total Return	-109.54%
Tr YTD	-40
Tr15y	-99.86%
Tr1m	-11.76%
Tr3m	-21.05%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	57,232,364%
Net Borrowing	236,064
Shares Insiders	8.44%
Shares Institutions	0.72%
Shares Out	62,506,542
Shares Qo Q	7.49%
Shares Yo Y	109.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -2.2M
Adjusted OCF	-2,162,514
Average Volume	71,714.95x
Bv Per Share	0.02
Ch10y	-96.59
Ch15y	-99.86
Ch1m	-11.76
Ch1y	-6.25
Ch3m	-21.05
Ch3y	-75
Ch5y	-92.11
Ch6m	-25
Change	7.14%
Change From Open	0
Close	0.07
Days Gap	7.14
Depreciation Amortization	14,146
Dollar Volume	450
Earnings Date	2026-11-27
EBIT	CAD -1.8M
EBITDA	CAD -1.7M
EPS	CAD -0.04
F Score	2
FCF	CAD -980,851
FCF EV Yield	-22.95x
FCF Per Share	CAD -0.02
Financing CF	2,396,240
Fiscal Year End	December
Founded	2,004
Goodwill	779,294
Investing CF	-944,116
Is Primary Listing	1
Last Earnings Date	2025-11-27
Last Report Date	2026-06-30
Last Split Date	2025-01-24
Last Split Type	Reverse
Ma150	0.1
Ma150ch	-24.7%
Ma20	0.08
Ma20ch	-8.87%
Net CF	471,273
Next Earnings Date	2026-11-27
Open	0.08
Ppne	66,236
Price Date	2026-09-03
Ptbv Ratio	8.59
Relative Volume	0.08x
Revenue	465,715x
SBC By Revenue	253.73x
Share Based Comp	1,181,663
Tr6m	-25%
Volume	6,000
Z Score	-42.78

CSE/HEAL (CSE/HEAL)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/HEAL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/HEAL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/HEAL

Frequently asked questions